Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants

Since the beginning of the 2021 year, all the main six vaccines against COVID-19 have been used in mass vaccination companies around the world. Virus neutralization and epidemiological efficacy drop obtained for several vaccines against the B.1.1.7, B.1.351 P.1, and B.1.617 genotypes are of concern....

Descripción completa

Detalles Bibliográficos
Autores principales: Gushchin, Vladimir A., Dolzhikova, Inna V., Shchetinin, Alexey M., Odintsova, Alina S., Siniavin, Andrei E., Nikiforova, Maria A., Pochtovyi, Andrei A., Shidlovskaya, Elena V., Kuznetsova, Nadezhda A., Burgasova, Olga A., Kolobukhina, Liudmila V., Iliukhina, Anna A., Kovyrshina, Anna V., Botikov, Andrey G., Kuzina, Aleksandra V., Grousova, Daria M., Tukhvatulin, Amir I., Shcheblyakov, Dmitry V., Zubkova, Olga V., Karpova, Oksana V., Voronina, Olga L., Ryzhova, Natalia N., Aksenova, Ekaterina I., Kunda, Marina S., Lioznov, Dmitry A., Danilenko, Daria M., Komissarov, Andrey B., Tkachuck, Artem P., Logunov, Denis Y., Gintsburg, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310330/
https://www.ncbi.nlm.nih.gov/pubmed/34358195
http://dx.doi.org/10.3390/vaccines9070779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310330/
https://www.ncbi.nlm.nih.gov/pubmed/34358195
http://dx.doi.org/10.3390/vaccines9070779

Ejemplares similares